Phase I Study PK Study With OXP005 and Naprosyn

NCT02351024 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: OXP005
DRUG: Naprosyn®

Sponsor

Oxford Pharmascience Ltd